news

news

News from the Lab (news.myScience.ch)

  • News from the Lab’ is a selection of scientific works that are significant or interesting for a broad readership. 
  • The selection of news is made by the team of myScience.ch. There is no right to be published or automatic publishing.
  •  RSS Feeds (Add this page to your bookmarks)
« BACK

Hannover Medical School (MHH)


Results 1 - 14 of 14.


Health - Life Sciences - 10.06.2022
Thanks to umbilical cord stem cells: First successful treatment of severe pulmonary hypertension
Thanks to umbilical cord stem cells: First successful treatment of severe pulmonary hypertension
Hannover Medical School doctors successfully treat three-year-old girl. Clinical researchers at Hannover Medical School (MHH) have succeeded for the first time worldwide in stopping the usually fatal course of the disease in severe pulmonary hypertension thanks to a novel therapeutic approach. A three-year-old girl suffering from so-called pulmonary arterial hypertension (PAH) was treated for six months a total of five times with mesenchymal stem cell products obtained from a human umbilical cord.

Health - Pharmacology - 31.05.2022
Drug combination triples survival time with blood cancer
Drug combination triples survival time with blood cancer
MHH involved in international study on acute myeloid leukaemia (AML) Acute myeloid leukaemia (AML) is a malignant disease in which the precursor cells of the haematopoietic system multiply uncontrollably. This form of blood cancer is caused by genetic changes in the bone marrow that occur in the course of life.

Health - Pharmacology - 26.04.2022
Liver fibrosis: the fatal signalling pathway
MHH research team clarifies how liver inflammation and scarring of liver tissue are connected At least five million people in Germany suffer from liver disease. Fibrosis, the pathological proliferation of connective tissue, plays an important role in many complications of chronic liver problems. Activated hepatic stellate cells (HSCs) are massively involved in this tissue remodelling.

Health - Life Sciences - 25.04.2022
Rapid diagnosis instead of a long odyssey
MHH Human Genetics: Whole-genome sequencing to bring the cause of rare diseases in critically ill children to light at an early stage About four million people in Germany suffer from one of the many different rare diseases (SE) - especially seriously ill children who require intensive medical treatment.

Health - Pharmacology - 05.04.2022
Researcher wants to stop harmful effect of chemotherapy on heart muscle
EU funds research project to elucidate pathological cardiac remodelling caused by cancer drugs with around 2.5 million euros 04. Heart failure is one of the most common causes of death worldwide. The disease, known in medicine as cardiac insufficiency, affects about four million people in Germany.

Health - 08.02.2022
Kidney failure in childhood: Gender influences survival chances
Kidney failure in childhood: Gender influences survival chances
MHH study: Vessels of girls suffer more damage than those of boys Gender plays a role: chronic kidney disease has a greater effect on the vessels of girls than on those of boys. Researchers at the Hannover Medical School (MHH) have now been able to show this in a European study. Although the mortality rate in children after kidney transplantation has fallen in recent decades, it is still very high compared to the general population due to early cardiovascular complications.

Health - Life Sciences - 05.11.2021
Success in the analysis of herpes viruses
Success in the analysis of herpes viruses
Team including MHH and RESIST researchers has found starting point for therapy of diseases caused by herpes viruses A research team from the University of Lübeck, Hannover Medical School (MHH), CSSB Hamburg and the RESIST Cluster of Excellence has found a possible new starting point for the therapy of diseases triggered by herpes viruses.

Health - Life Sciences - 19.10.2021
New values for better diagnoses
New values for better diagnoses
MHH study develops reference tool for blood tests Lymphocytes belong to the white blood cells. They consist of several subgroups with different tasks in immune defence. Which and how many lymphocytes are in the blood provides information about our current state of health as well as congenital or acquired immune deficiencies.

Health - Pharmacology - 14.10.2021
Help for the weakened heart
Help for the weakened heart
MHH research team demonstrates how inflammatory cells improve the function of diseased heart muscle cells Heart failure or cardiac insufficiency is one of the most common causes of death in Germany and is caused by heart attacks, high blood pressure or heart valve defects. The heart is then no longer able to pump a sufficient amount of blood through the body and supply organs, muscles or other tissues with enough oxygen and nutrients.

Health - Life Sciences - 13.10.2021
New test improves diagnosis of rare liver disease
New test improves diagnosis of rare liver disease
Polyreactive antibodies as markers for autoimmune hepatitis Autoimmune hepatitis (AIH) is a chronic liver inflammation that is triggered by an immunological malfunction. In this case, the immune system falsely recognises the patient's own liver cells as "foreign to the body". The symptoms of this rare liver disease are unspecific, and the exact cause is not yet known.

Health - Life Sciences - 07.07.2021
MHH fills important gap in lung research
MHH fills important gap in lung research
For the first time, a team of scientists clearly demonstrates the existence of lipofibroblasts in human luectron microscope In medical research, animal models are used to clarify the development of diseases and to develop suitable therapies. In order to be able to transfer the results to humans, however, it must be ensured that the cell types and molecular signalling pathways studied in detail actually occur in our bodies.

Life Sciences - Health - 01.06.2021
Main switch for hereditary muscle atrophy found
Main switch for hereditary muscle atrophy found
Research team investigates molecular mechanisms of spinal muscular atrophy (SMA) Stand: 01. Spinal muscular atrophy (SMA) is a hereditary neurodegenerative disease. Motor nerve cells in the spinal cord and brain stem, which are connected to the muscles and control their movements, gradually die. The result is massive muscle atrophy, which in severe cases can lead to death in infancy if left untreated.

Health - 19.05.2021
New oxygen therapy reduces consequences of heart attack
New oxygen therapy reduces consequences of heart attack
For the first time in Europe: Cardiologists use "SuperSaturated Oxygen" procedure to reduce heart muscle damage In Germany, more than 200,000 people suffer a heart attack every year. Despite good medical care, many are left with reduced cardiac output. This is particularly true for patients with severe heart attacks: more than 30 percent of those affected develop heart failure, and almost half of them die within the next five years.

Health - Life Sciences - 18.05.2021
New treatment against brain inflammation
New treatment against brain inflammation
MHH: Successful healing trial with immune cells against JC virus The John Cunningham (JC) virus infects about 70 to 90 percent of all people worldwide without most of them even noticing it. But once it has entered the body, the genetic material of the pathogen remains dormant. If the immune system is weakened or shut down by a serious illness or by immunosuppressive drugs, the virus is reactivated and multiplies.